Home/Filings/4/0001104659-22-040397
4//SEC Filing

Lizak Carol R. 4

Accession 0001104659-22-040397

CIK 0001585608other

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 9:32 PM ET

Size

8.0 KB

Accession

0001104659-22-040397

Insider Transaction Report

Form 4
Period: 2021-09-13
Lizak Carol R.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2021-09-13$2.51/sh+7,968$20,0007,968 total(indirect: See Footnote)
  • Award

    Restricted stock units

    2022-03-28+97,02597,025 total
    Common Stock (97,025 underlying)
Footnotes (5)
  • [F1]Securities held directly by the Peter & Carol Lizak Revocable Trust. Ms. Lizak, by virtue of her position as a co-trustee and beneficiary of such trust and her sharing of voting and investment control over the securities held by the trust with her spouse, may be deemed to beneficially own the securities held by the Peter & Carol Lizak Trust for purposes of Section 16.
  • [F2]Granted pursuant to the issuer's 2014 Stock Incentive Plan.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F4]The restricted stock unit grants were approved by the issuer's board of directors on March 28, 2022.
  • [F5]The restricted stock units vest in three equal annual installments beginning on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.

Issuer

Jaguar Health, Inc.

CIK 0001585608

Entity typeother

Related Parties

1
  • filerCIK 0001785794

Filing Metadata

Form type
4
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 9:32 PM ET
Size
8.0 KB